Overview
Intra-tumor Injection of Drug-eluting Microspheres
Status:
Recruiting
Recruiting
Trial end date:
2023-11-01
2023-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To study the safety and clinical effect of injection of drug-eluting microspheres into advanced solid tumors.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Criteria
Inclusion Criteria:- Solid advanced malignant tumors
- Age between18 and 99 years
- Life expectancy is greater than three months
Exclusion Criteria:
- Benign tumor
- Life expectancy is less than three months
- Serious medical comorbidity
- Others